- Home
- EVF vs COEP Comparison
EVF vs COEP Comparison
Compare EVF & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVF
- COEP
- Stock Information
- Founded
- EVF 1998
- COEP 2017
- Country
- EVF United States
- COEP United States
- Employees
- EVF N/A
- COEP N/A
- Industry
- EVF Investment Managers
- COEP Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVF Finance
- COEP Health Care
- Exchange
- EVF Nasdaq
- COEP Nasdaq
- Market Cap
- EVF 101.0M
- COEP 86.0M
- IPO Year
- EVF N/A
- COEP N/A
- Fundamental
- Price
- EVF $5.48
- COEP $16.95
- Analyst Decision
- EVF
- COEP
- Analyst Count
- EVF 0
- COEP 0
- Target Price
- EVF N/A
- COEP N/A
- AVG Volume (30 Days)
- EVF 93.3K
- COEP 63.6K
- Earning Date
- EVF 01-01-0001
- COEP 11-12-2025
- Dividend Yield
- EVF 10.68%
- COEP N/A
- EPS Growth
- EVF N/A
- COEP N/A
- EPS
- EVF 0.94
- COEP N/A
- Revenue
- EVF N/A
- COEP $263,555.00
- Revenue This Year
- EVF N/A
- COEP N/A
- Revenue Next Year
- EVF N/A
- COEP N/A
- P/E Ratio
- EVF $6.74
- COEP N/A
- Revenue Growth
- EVF N/A
- COEP N/A
- 52 Week Low
- EVF $5.20
- COEP $2.31
- 52 Week High
- EVF $6.84
- COEP $19.19
- Technical
- Relative Strength Index (RSI)
- EVF 34.47
- COEP 59.29
- Support Level
- EVF $5.47
- COEP $16.00
- Resistance Level
- EVF $5.52
- COEP $18.15
- Average True Range (ATR)
- EVF 0.04
- COEP 1.60
- MACD
- EVF -0.00
- COEP 0.06
- Stochastic Oscillator
- EVF 20.80
- COEP 63.31
About EVF Eaton Vance Senior Income Trust
Eaton Vance Senior Income Trust is a United States-based diversified, closed-end management investment company. Its investment objective is to provide a high level of current income consistent with the preservation of capital, by investing in senior, secured floating-rate loans. The trust invests in below-investment-grade floating-rate loans, which are considered speculative because of the credit risk of their issuers. Its portfolio of investment consists of aerospace and defense, automotive, beverage, building and development, business equipment and services, cable and satellite television, and other areas.
About COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.